2018 Q1 Form 10-Q Financial Statement
#000114420418027786 Filed on May 14, 2018
Income Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| Revenue | $400.1K | $0.00 |
| YoY Change | -100.0% | |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $1.390M | $1.190M |
| YoY Change | 16.81% | 10.19% |
| % of Gross Profit | ||
| Research & Development | $2.697M | $3.260M |
| YoY Change | -17.28% | -24.9% |
| % of Gross Profit | ||
| Depreciation & Amortization | $34.06K | $38.77K |
| YoY Change | -12.15% | 22.68% |
| % of Gross Profit | ||
| Operating Expenses | $4.086M | $4.450M |
| YoY Change | -8.17% | -17.98% |
| Operating Profit | -$3.686M | |
| YoY Change | ||
| Interest Expense | $0.00 | -$100.0K |
| YoY Change | -100.0% | -251.23% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $14.65K | |
| YoY Change | ||
| Pretax Income | -$3.670M | -$3.670M |
| YoY Change | 0.0% | -14.05% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$3.672M | -$3.670M |
| YoY Change | 0.04% | -13.98% |
| Net Earnings / Revenue | -917.73% | |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$1.364M | -$1.715M |
| COMMON SHARES | ||
| Basic Shares Outstanding | 27.71M shares | 21.40M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $13.16M | $11.74M |
| YoY Change | 12.1% | -17.68% |
| Cash & Equivalents | $7.169M | $2.750M |
| Short-Term Investments | $5.995M | $8.993M |
| Other Short-Term Assets | $1.140M | $1.530M |
| YoY Change | -25.49% | 378.12% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $14.61M | $13.46M |
| YoY Change | 8.54% | -9.6% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $540.0K | $410.0K |
| YoY Change | 31.71% | 18.86% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $160.0K | $60.00K |
| YoY Change | 166.67% | -14.29% |
| Total Long-Term Assets | $780.0K | $608.0K |
| YoY Change | 28.28% | -70.98% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $14.61M | $13.46M |
| Total Long-Term Assets | $780.0K | $608.0K |
| Total Assets | $15.39M | $14.07M |
| YoY Change | 9.4% | -17.17% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.480M | $2.620M |
| YoY Change | -43.51% | -29.0% |
| Accrued Expenses | ||
| YoY Change | ||
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $1.480M | $3.299M |
| YoY Change | -55.14% | -55.06% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $3.380M | $17.01M |
| YoY Change | -80.13% | 67.42% |
| Other Long-Term Liabilities | $950.0K | |
| YoY Change | 66.67% | |
| Total Long-Term Liabilities | $3.380M | $17.96M |
| YoY Change | -81.18% | 67.43% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $1.480M | $3.299M |
| Total Long-Term Liabilities | $3.380M | $17.96M |
| Total Liabilities | $4.850M | $21.26M |
| YoY Change | -77.19% | 17.67% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$55.22M | -$57.65M |
| YoY Change | -4.21% | 46.17% |
| Common Stock | $27.97K | $50.42M |
| YoY Change | -99.94% | 31.53% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $10.53M | -$7.192M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $15.39M | $14.07M |
| YoY Change | 9.4% | -17.17% |
Cashflow Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$3.672M | -$3.670M |
| YoY Change | 0.04% | -13.98% |
| Depreciation, Depletion And Amortization | $34.06K | $38.77K |
| YoY Change | -12.15% | 22.68% |
| Cash From Operating Activities | -$3.418M | -$4.676M |
| YoY Change | -26.91% | 11.86% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $186.4K | $3.126K |
| YoY Change | 5862.44% | -93.18% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $2.000M | $4.000M |
| YoY Change | -50.0% | -27.14% |
| Cash From Investing Activities | $1.812M | $4.001M |
| YoY Change | -54.71% | -26.59% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $2.373M | $0.00 |
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 2.513M | $0.00 |
| YoY Change | -100.0% | |
| NET CHANGE | ||
| Cash From Operating Activities | -3.418M | -$4.676M |
| Cash From Investing Activities | 1.812M | $4.001M |
| Cash From Financing Activities | 2.513M | $0.00 |
| Net Change In Cash | 906.6K | -$675.3K |
| YoY Change | -234.24% | -110.89% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$3.418M | -$4.676M |
| Capital Expenditures | $186.4K | $3.126K |
| Free Cash Flow | -$3.604M | -$4.679M |
| YoY Change | -22.97% | 10.72% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q1 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
0 | USD |
| CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-55219349 | USD |
| CY2018Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
619427 | USD |
| CY2017Q4 | us-gaap |
Other Long Term Debt
OtherLongTermDebt
|
3376259 | USD |
| CY2017Q4 | us-gaap |
Grants Receivable Current
GrantsReceivableCurrent
|
344575 | USD |
| CY2018Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
27971 | USD |
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
26271 | USD |
| CY2017Q1 | capr |
Collaboration Revenue
CollaborationRevenue
|
683594 | USD |
| CY2018Q1 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
306750 | USD |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
400066 | USD |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2696517 | USD |
| CY2018Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1389732 | USD |
| CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4086249 | USD |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3686183 | USD |
| CY2018Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
14653 | USD |
| CY2018Q1 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
| CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
14653 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3671530 | USD |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
8709 | USD |
| CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3662821 | USD |
| CY2018Q1 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
93316 | USD |
| CY2018Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
3001871 | USD |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
26905331 | shares |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2373478 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
8000000 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
5000000 | USD |
| CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3126 | USD |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
186386 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
4000591 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1811743 | USD |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
457612 | USD |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
139140 | USD |
| CY2017Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
38772 | USD |
| CY2018Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
34060 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
471790 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
457612 | USD |
| CY2017Q1 | capr |
Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
|
-26121 | USD |
| CY2018Q1 | capr |
Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
|
-37825 | USD |
| CY2017Q1 | capr |
Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
|
55283 | USD |
| CY2018Q1 | capr |
Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
|
21182 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
|
0 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
|
61818 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-532979 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-87913 | USD |
| CY2017Q1 | capr |
Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
|
-379421 | USD |
| CY2018Q1 | capr |
Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
|
-104863 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
105320 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-683594 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4675891 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3417809 | USD |
| CY2017Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
3996283 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2512618 | USD |
| CY2017Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
| CY2018Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
| CY2018Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2373478 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
906552 | USD |
| CY2017Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-675300 | USD |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6882137 | USD |
| CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4551603 | USD |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7788689 | USD |
| CY2017Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3876303 | USD |
| CY2018Q1 | capr |
Amount Available Under Grant And Loan Awards
AmountAvailableUnderGrantAndLoanAwards
|
4900000 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2750473 | USD |
| CY2017Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
1125830 | USD |
| CY2018Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
600000 | USD |
| CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
700000 | USD |
| CY2018Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
364891 | USD |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
341650 | USD |
| CY2018Q1 | us-gaap |
Depreciation
Depreciation
|
23241 | USD |
| CY2017Q1 | us-gaap |
Depreciation
Depreciation
|
26584 | USD |
| CY2018Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10819 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
12187 | USD |
| CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
43276 | USD |
| CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
4330 | USD |
| CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
2165 | USD |
| CY2018Q1 | us-gaap |
Marketable Securities
MarketableSecurities
|
5995380 | USD |
| CY2018Q1 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
300001 | USD |
| CY2017Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
7984800 | USD |
| CY2017 | capr |
Loan Payable Forgiven
LoanPayableForgiven
|
15700000 | USD |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27970879 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
26270491 | shares |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.14 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.17 | |
| CY2018Q1 | capr |
Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
|
0 | shares |
| CY2018Q1 | capr |
Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
|
0 | |
| CY2018Q1 | capr |
Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
|
0 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
12500 | shares |
| CY2018Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
12500 | shares |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
22750 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.86 | |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.45 | |
| CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
434863 | USD |
| CY2017Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
471790 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
521678 | USD |
| CY2018Q1 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
13400000 | USD |
| CY2017Q4 | capr |
Disbursement Amount Under Grant Award
DisbursementAmountUnderGrantAward
|
300000 | USD |
| CY2018Q1 | capr |
Payments For Reimbursement For Research And Development Expenses Incurred Related Party
PaymentsForReimbursementForResearchAndDevelopmentExpensesIncurredRelatedParty
|
200000 | USD |
| CY2017Q1 | capr |
Payments For Reimbursement For Research And Development Expenses Incurred Related Party
PaymentsForReimbursementForResearchAndDevelopmentExpensesIncurredRelatedParty
|
500000 | USD |
| CY2018Q1 | us-gaap |
Due From Related Parties
DueFromRelatedParties
|
2100000 | USD |
| CY2018Q1 | us-gaap |
Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
|
93000 | USD |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2018Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. The most sensitive estimates relate to the recoverability and fair value of intangible assets and the assumptions used to estimate stock-based compensation expense. Management uses its historical records and knowledge of its business in making these estimates. Accordingly, actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2018Q1 | capr |
Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
|
0 | shares |
| CY2018Q1 | capr |
Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
|
0 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
713746 | USD |
| CY2018Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
900132 | USD |
| CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
32458 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2016Q4 | capr |
Disbursement Amount Under Grant Award
DisbursementAmountUnderGrantAward
|
3100000 | USD |
| CY2018Q1 | us-gaap |
Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
|
4190 | USD |
| CY2017Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
122500 | USD |
| CY2017Q4 | capr |
Reimbursed Expenses To Be Paid
ReimbursedExpensesToBePaid
|
50000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
15700000 | USD |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8077236 | shares |
| CY2017Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8261999 | shares |
